Income Statement Granules India Limited

Stocks

GRANULES

INE101D01020

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:52 10/07/2026 BST			5-day change	1st Jan Change
889.55 ^INR	+0.95%		+6.77%	+48.62%

07-06	Granules India Gets Sole First-to-File Status for Sodium Oxybate Extended-Release for Oral Suspension	MT
06-12	Sushil Finance Starts Granules India at Buy with INR963 Price Target	MT

d.wKXdkn2-IzVcLd2wW8HUqohPmwhEWr84I1sDKfd1yiE.kZOXoAfhWWI0VZyFH7m38MwN70V8A8cBdihFcLoNjW-klqnHLchkBw9OlA

Published financial data: GRANULES INDIA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	32.38B	37.65B	45.12B	45.06B	44.82B
Total Revenues	32.38B	37.65B	45.12B	45.06B	44.82B
Cost of Goods Sold, Total	14.61B	19.68B	23.92B	21.31B	18.56B
Gross Profit	17.77B	17.97B	21.2B	23.76B	26.25B
Selling General & Admin Expenses, Total	4.22B	4.26B	4.87B	6.24B	6.75B
Provision for Bad Debts	24.63M	10K	540K	24.36M	66.59M
Stock-Based Compensation (IS)	15.55M	-	-	-	-
Depreciation & Amortization - (IS)	1.51B	1.59B	1.84B	2.07B	2.26B
Other Operating Expenses	4.86B	6.32B	7.1B	8.89B	9.96B
Other Operating Expenses, Total	10.64B	12.16B	13.82B	17.23B	19.03B
Operating Income	7.13B	5.81B	7.38B	6.53B	7.22B
Interest Expense, Total	-196M	-118M	-354M	-718M	-607M
Interest And Investment Income	124M	129M	45.14M	27.97M	37.42M
Net Interest Expenses	-72.39M	10.15M	-309M	-690M	-569M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-82.01M	-65.09M	-69.46M	-18.58M	-1.32M
Other Non Operating Income (Expenses)	78.37M	-66.18M	-112M	-325M	-334M
EBT, Excl. Unusual Items	7.05B	5.69B	6.89B	5.5B	6.32B
Gain (Loss) On Sale Of Investments	-	-	-	-	140K
Gain (Loss) On Sale Of Assets	-3.92M	-47.83M	-13.71M	-23.2M	-24.88M
Asset Writedown	-7.29M	-	-	-	-
Other Unusual Items	-	-61.52M	-	-	308M
EBT, Incl. Unusual Items	7.04B	5.58B	6.87B	5.47B	6.6B
Income Tax Expense	1.55B	1.45B	1.71B	1.42B	1.59B
Earnings From Continuing Operations	5.49B	4.13B	5.17B	4.05B	5.02B
Net Income to Company	5.49B	4.13B	5.17B	4.05B	5.02B
Minority Interest	-	-2K	-	-	-
Net Income - (IS)	5.49B	4.13B	5.17B	4.05B	5.02B
Net Income to Common Incl Extra Items	5.49B	4.13B	5.17B	4.05B	5.02B
Net Income to Common Excl. Extra Items	5.49B	4.13B	5.17B	4.05B	5.02B
Per Share Items
Net EPS - Basic	22.05	16.65	21.05	16.73	20.69
Basic EPS - Continuing Operations	22.05	16.65	21.05	16.73	20.69
Basic Weighted Average Shares Outstanding	249M	248M	245M	242M	242M
Net EPS - Diluted	21.95	16.6	21	16.72	20.68
Diluted EPS - Continuing Operations	21.95	16.6	21	16.72	20.68
Diluted Weighted Average Shares Outstanding	250M	249M	246M	242M	242M
Normalized Basic EPS	17.69	14.35	17.54	14.18	16.29
Normalized Diluted EPS	17.62	14.3	17.51	14.17	16.29
Dividend Per Share	1.5	1.5	1.5	1.5	1.5
Payout Ratio	4.5	9.01	3.6	8.96	7.25
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	8.6B	7.32B	9.13B	8.48B	9.3B
EBITA	7.47B	6.15B	7.77B	6.98B	7.72B
EBIT	7.13B	5.81B	7.38B	6.53B	7.22B
EBITDAR	8.68B	7.4B	9.24B	8.7B	9.44B
Total Revenues (As Reported)	32.64B	37.83B	45.26B	45.11B	44.95B
Effective Tax Rate - (Ratio)	21.99	26.03	24.82	25.93	24.03
Total Current Taxes	1.95B	1.38B	1.77B	1.65B	1.83B
Total Deferred Taxes	-405M	70.35M	-66.04M	-233M	-242M
Normalized Net Income	4.41B	3.56B	4.3B	3.43B	3.95B
Interest Capitalized	-	-	-	-	129M
Interest on Long-Term Debt	137M	67.8M	59.79M	100M	151M
Non-Cash Pension Expense	11.47M	14.38M	18.36M	21M	24.68M
Supplemental Operating Expense Items
Advertising Expense	63.26M	164M	37.03M	44.54M	13.12M
Selling and Marketing Expenses	63.26M	164M	37.03M	44.54M	13.12M
Research And Development Expense From Footnotes	1B	1.43B	1.16B	1.99B	2.38B
Net Rental Expense, Total	78.25M	79.67M	112M	220M	140M
Imputed Operating Lease Interest Expense	14.11M	7.72M	28.21M	103M	59.48M
Imputed Operating Lease Depreciation	64.15M	71.95M	83.4M	117M	80.56M
Maintenance & Repair Expenses, Total	695M	841M	850M	1.09B	1.3B
Stock-Based Comp., SG&A Exp. (Total)	24.44M	18.38M	12.9M	2.82M	-
Stock-Based Comp., Other (Total)	15.55M	-	-	-	-
Total Stock-Based Compensation	39.99M	18.38M	12.9M	2.82M	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	418M	1.85B	2.92B	3.81B	4.66B
Short Term Investments	2.21B	2.11B	-	-	28.55M
Total Cash And Short Term Investments	2.63B	3.96B	2.92B	3.81B	4.69B
Accounts Receivable, Total	7.65B	9.25B	9.49B	9.86B	9.42B
Other Receivables	364M	217M	126M	149M	130M
Notes Receivable	99.93M	75.13M	-	-	-
Total Receivables	8.12B	9.54B	9.61B	10.01B	9.55B
Inventory	7.82B	9.79B	11.49B	13.01B	13.43B
Prepaid Expenses	143M	204M	361M	311M	409M
Restricted Cash	-	-	-	-	1.1B
Other Current Assets, Total	1.25B	1.56B	1.36B	1.92B	1.98B
Total Current Assets	19.97B	25.05B	25.74B	29.05B	31.15B
Gross Property Plant And Equipment	19.17B	23.25B	27.21B	31.13B	38.12B
Accumulated Depreciation	-6.61B	-7.29B	-8.61B	-9.98B	-11.58B
Net Property Plant And Equipment	12.56B	15.96B	18.59B	21.16B	26.54B
Long-term Investments	190M	197M	212M	215M	231M
Other Intangibles, Total	3.15B	3.02B	2.91B	2.52B	2.12B
Loans Receivable Long-Term	131M	29.8M	-	-	-
Deferred Tax Assets Long-Term	7.73M	13.74M	14.28M	371M	678M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	1.12B	865M	1.57B	1.9B	1.8B
Total Assets	37.13B	45.13B	49.05B	55.21B	62.53B
Liabilities
Accounts Payable, Total	5.41B	6.39B	7.82B	7.5B	7.26B
Accrued Expenses, Total	495M	543M	643M	789M	1.11B
Short-term Borrowings	4.09B	7.66B	8.11B	10.54B	9.23B
Current Portion of Long-Term Debt	954M	935M	991M	1B	517M
Current Portion of Leases	34.22M	52.72M	70.11M	86.4M	97.79M
Current Income Taxes Payable	152M	137M	127M	56.09M	182M
Unearned Revenue Current, Total	133M	66.12M	63.98M	178M	43.76M
Other Current Liabilities	461M	640M	310M	675M	1.59B
Total Current Liabilities	11.73B	16.42B	18.14B	20.82B	20.03B
Long-Term Debt	3.34B	2.34B	1.49B	690M	3.12B
Long-Term Leases	73.36M	82.81M	706M	832M	1.59B
Pension & Other Post Retirement Benefits	176M	205M	219M	287M	318M
Deferred Tax Liability Non Current	10.92M	139M	76.52M	231M	314M
Other Non Current Liabilities	72.07M	77.74M	73.48M	91.6M	-
Total Liabilities	15.4B	19.26B	20.7B	22.95B	25.37B
Common Stock, Total	248M	248M	242M	242M	243M
Additional Paid In Capital	4.53B	4.56B	1.49B	1.52B	1.57B
Retained Earnings	16.64B	20.39B	25.37B	29.03B	33.66B
Comprehensive Income and Other	319M	664M	1.25B	1.46B	1.68B
Total Common Equity	21.73B	25.87B	28.35B	32.26B	37.16B
Minority Interest	-	5.58M	-	-	-
Total Equity	21.73B	25.87B	28.35B	32.26B	37.16B
Total Liabilities And Equity	37.13B	45.13B	49.05B	55.21B	62.53B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	248M	248M	242M	242M	243M
ECS Total Common Shares Outstanding	248M	248M	242M	242M	243M
Book Value / Share	87.75	104.29	117.12	133.08	153.19
Tangible Book Value	18.58B	22.85B	25.44B	29.74B	35.03B
Tangible Book Value Per Share	75.03	92.13	105.11	122.7	144.44
Total Debt	8.49B	11.06B	11.36B	13.15B	14.55B
Net Debt	5.86B	7.1B	8.45B	9.34B	9.86B
Debt Equivalent of Unfunded Proj. Benefit Obligation	213M	263M	285M	353M	389M
Debt Equivalent Oper. Leases	626M	637M	893M	1.76B	1.12B
Minority Interest, Total (Incl. Fin. Div)	-	5.58M	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	2.97B	3.4B	4.57B	4.14B	4.38B
Inventories - Work In Process, Total	593M	1.38B	1.41B	1.22B	1.32B
Inventories - Finished Goods, Total	3.96B	4.7B	5.13B	7.18B	7.08B
Inventories - Others	295M	307M	389M	463M	653M
Land - (BS)	527M	835M	864M	877M	1.15B
Buildings, Total	5.13B	6.06B	7.1B	7.35B	8.49B
Machinery, Total	11.48B	12.98B	15.96B	17.96B	20.63B
Full Time Employees	3.37K	3.69K	3.65K	4.06K	4.07K
Accumulated Allowance for Doubtful Accounts (Supple)	300M	293M	288M	339M	363M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	5.49B	4.13B	5.17B	4.05B	5.02B
Depreciation & Amortization - CF	1.16B	1.22B	1.43B	1.6B	1.73B
Amortization of Goodwill and Intangible Assets - (CF)	340M	338M	393M	448M	493M
Depreciation & Amortization, Total	1.49B	1.56B	1.82B	2.05B	2.22B
Amortization of Deferred Charges, Total - (CF)	19.64M	25.75M	22.17M	21.57M	34.13M
(Gain) Loss From Sale Of Asset	3.92M	47.83M	13.71M	23.2M	24.88M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-140K
Asset Writedown & Restructuring Costs	7.29M	-	-	-	-
Stock-Based Compensation (CF)	39.99M	16.22M	12.89M	2.82M	-
Provision and Write-off of Bad Debts	99.63M	-6.1M	-4.53M	74.77M	43.23M
Other Operating Activities, Total	-85.8M	121M	458M	630M	1.27B
Change In Accounts Receivable	-364M	-1.31B	-770K	-307M	359M
Change In Inventories	-3.46B	-1.84B	-1.35B	-1.41B	-206M
Change In Accounts Payable	1.53B	740M	1.09B	-38.66M	37.19M
Change in Other Net Operating Assets	-455M	-160M	161M	-710M	-130M
Cash from Operations	4.32B	3.32B	7.39B	4.39B	8.67B
Capital Expenditure	-2.71B	-3.98B	-4.11B	-3.81B	-5.72B
Sale of Property, Plant, and Equipment	3.27M	9.79M	2.12M	17.49M	17.03M
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-215M	44.77M	2.03B	159M	-1.25B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	106M	-	-
Other Investing Activities, Total	154M	121M	50.54M	27.74M	35.96M
Cash from Investing	-2.77B	-3.8B	-1.91B	-3.6B	-6.91B
Short Term Debt Issued, Total	296M	3.49B	460M	19.52B	21.07B
Long-Term Debt Issued, Total	-	-	-	190M	2.94B
Total Debt Issued	296M	3.49B	460M	19.7B	24.01B
Short Term Debt Repaid, Total	-	-	-	-17.14B	-22.41B
Long-Term Debt Repaid, Total	-1.05B	-1.01B	-1.06B	-1.13B	-1.18B
Total Debt Repaid	-1.05B	-1.01B	-1.06B	-18.27B	-23.59B
Issuance of Common Stock	41.45M	37.07M	27.84M	31.62M	49.98M
Repurchase of Common Stock	-1.77B	-	-3.11B	-	-
Common Dividends Paid	-247M	-372M	-186M	-363M	-364M
Common & Preferred Stock Dividends Paid	-247M	-372M	-186M	-363M	-364M
Other Financing Activities, Total	-263M	-242M	-538M	-1.03B	-1.03B
Cash from Financing	-2.99B	1.9B	-4.4B	76.64M	-925M
Foreign Exchange Rate Adjustments	-1.23M	9.41M	-2.53M	26.25M	22.4M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-1.44B	1.43B	1.07B	895M	850M
Supplemental Items
Cash Interest Paid	263M	242M	533M	1.03B	1.03B
Cash Income Tax Paid (Refund)	1.91B	1.45B	1.76B	1.9B	1.44B
Levered Free Cash Flow	2.17B	-1.44B	1.59B	-283M	445M
Unlevered Free Cash Flow	2.29B	-1.37B	1.82B	166M	824M
Change In Net Working Capital	1.01B	2.63B	545M	2.18B	229M
Net Debt Issued / Repaid	-753M	2.48B	-600M	1.43B	423M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.84	8.83	9.79	7.83	7.67
Return on Total Capital	15.48	10.81	12.03	9.59	9.3
Return On Equity %	27.36	17.34	19.06	13.38	14.45
Return on Common Equity	27.36	17.34	19.06	13.38	14.45
Margin Analysis
Gross Profit Margin %	54.88	47.74	46.98	52.72	58.58
SG&A Margin	13.04	11.31	10.8	13.85	15.06
EBITDA Margin %	26.55	19.45	20.24	18.81	20.75
EBITA Margin %	23.07	16.33	17.22	15.48	17.22
EBIT Margin %	22.03	15.43	16.35	14.49	16.12
Income From Continuing Operations Margin %	16.97	10.96	11.45	8.99	11.19
Net Income Margin %	16.97	10.96	11.45	8.99	11.19
Net Avail. For Common Margin %	16.97	10.96	11.45	8.99	11.19
Normalized Net Income Margin	13.62	9.44	9.54	7.62	8.81
Levered Free Cash Flow Margin	6.7	-3.83	3.53	-0.63	0.99
Unlevered Free Cash Flow Margin	7.08	-3.64	4.03	0.37	1.84
Asset Turnover
Asset Turnover	0.93	0.92	0.96	0.86	0.76
Fixed Assets Turnover	2.71	2.64	2.61	2.27	1.88
Receivables Turnover (Average Receivables)	4.54	4.45	4.82	4.66	4.65
Inventory Turnover (Average Inventory)	2.39	2.24	2.25	1.74	1.4
Short Term Liquidity
Current Ratio	1.7	1.53	1.42	1.4	1.56
Quick Ratio	0.91	0.82	0.69	0.66	0.71
Operating Cash Flow to Current Liabilities	0.37	0.2	0.41	0.21	0.43
Days Sales Outstanding (Average Receivables)	80.47	81.94	75.78	78.55	78.51
Days Outstanding Inventory (Average Inventory)	152.49	163.3	162.34	210.42	259.9
Average Days Payable Outstanding	90.81	99.48	101.16	122.84	141.85
Cash Conversion Cycle (Average Days)	142.15	145.76	136.96	166.14	196.56
Long Term Solvency
Total Debt/Equity	39.08	42.76	40.08	40.77	39.15
Total Debt / Total Capital	28.1	29.95	28.61	28.96	28.14
LT Debt/Equity	15.7	9.35	7.73	4.72	12.67
Long-Term Debt / Total Capital	11.29	6.55	5.52	3.35	9.1
Total Liabilities / Total Assets	41.48	42.67	42.2	41.58	40.58
EBIT / Interest Expense	36.35	49.08	20.82	9.1	11.91
EBITDA / Interest Expense	43.97	62.26	25.97	11.96	15.57
(EBITDA - Capex) / Interest Expense	30.14	28.67	14.38	6.65	6.14
Total Debt / EBITDA	0.98	1.5	1.24	1.53	1.54
Net Debt / EBITDA	0.68	0.96	0.92	1.09	1.04
Total Debt / (EBITDA - Capex)	1.44	3.26	2.23	2.75	3.9
Net Debt / (EBITDA - Capex)	0.99	2.09	1.66	1.96	2.64
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.59	16.29	19.84	-0.12	-0.55
Gross Profit, 1 Yr. Growth %	42.15	1.15	17.94	12.08	10.51
EBITDA, 1 Yr. Growth %	55.27	-15.25	25.74	-7.16	9.7
EBITA, 1 Yr. Growth %	61.84	-18.19	27.64	-10.21	10.61
EBIT, 1 Yr. Growth %	69.14	-19.03	28.31	-11.5	10.65
Earnings From Cont. Operations, 1 Yr. Growth %	63.82	-24.88	25.16	-21.54	23.74
Net Income, 1 Yr. Growth %	63.82	-24.88	25.16	-21.54	23.74
Normalized Net Income, 1 Yr. Growth %	54.5	-19.87	22.35	-20.19	14.98
Diluted EPS Before Extra, 1 Yr. Growth %	66.92	-24.37	26.51	-20.38	23.68
Accounts Receivable, 1 Yr. Growth %	15.62	20.84	2.55	3.93	-4.42
Inventory, 1 Yr. Growth %	78.4	25.11	17.46	13.15	3.25
Net Property, Plant and Equip., 1 Yr. Growth %	10.48	27.04	16.53	13.78	25.46
Total Assets, 1 Yr. Growth %	15.03	21.53	8.68	12.57	13.25
Tangible Book Value, 1 Yr. Growth %	25.35	22.96	11.35	16.9	17.8
Common Equity, 1 Yr. Growth %	17.87	19.02	9.6	13.78	15.19
Cash From Operations, 1 Yr. Growth %	-9.18	-23.22	122.48	-40.52	97.21
Capital Expenditures, 1 Yr. Growth %	47.09	46.57	3.26	-7.33	50.22
Levered Free Cash Flow, 1 Yr. Growth %	281.25	-165.7	-207.62	-117.72	-257.45
Unlevered Free Cash Flow, 1 Yr. Growth %	225.36	-159.04	-229.01	-90.87	397.03
Dividend Per Share, 1 Yr. Growth %	50	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.18	20.37	18.05	9.4	-0.34
Gross Profit, 2 Yr. CAGR %	35.58	19.91	9.22	14.97	11.29
EBITDA, 2 Yr. CAGR %	49.85	15.02	2.79	8.05	0.92
EBITA, 2 Yr. CAGR %	58.54	15.42	1.67	7.06	-0.34
EBIT, 2 Yr. CAGR %	59.89	17.4	1.38	6.56	-1.04
Earnings From Cont. Operations, 2 Yr. CAGR %	52.45	10.93	-3.04	-0.91	-1.47
Net Income, 2 Yr. CAGR %	52.45	10.93	-3.04	-0.91	-1.47
Normalized Net Income, 2 Yr. CAGR %	47.13	11.62	-1.53	-1.18	-4.2
Diluted EPS Before Extra, 2 Yr. CAGR %	53.8	12.35	-2.19	0.36	-0.76
Accounts Receivable, 2 Yr. CAGR %	6.6	18.2	11.32	3.24	-0.33
Inventory, 2 Yr. CAGR %	42.68	49.4	21.22	15.28	8.09
Net Property, Plant and Equip., 2 Yr. CAGR %	8.29	18.47	21.67	15.15	19.48
Total Assets, 2 Yr. CAGR %	11.58	18.23	14.92	10.61	12.91
Tangible Book Value, 2 Yr. CAGR %	26.55	24.15	17.01	14.09	17.35
Common Equity, 2 Yr. CAGR %	19.2	18.44	14.21	11.67	14.48
Cash From Operations, 2 Yr. CAGR %	28.42	-16.49	30.7	15.04	8.31
Capital Expenditures, 2 Yr. CAGR %	-1.45	46.83	23.02	-2.18	17.99
Levered Free Cash Flow, 2 Yr. CAGR %	67.44	59.3	-14.8	-56.32	-47.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	90.5	39.45	-11.51	-65.68	-32.63
Dividend Per Share, 2 Yr. CAGR %	22.47	22.47	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.33	18.21	20.19	11.65	5.98
Gross Profit, 3 Yr. CAGR %	33.53	22.97	19.25	10.17	13.47
EBITDA, 3 Yr. CAGR %	45.61	24.14	18.15	-0.64	8.6
EBITA, 3 Yr. CAGR %	52.33	27.42	18.96	-2.45	8.23
EBIT, 3 Yr. CAGR %	52.19	27.72	20.5	-3.11	7.91
Earnings From Cont. Operations, 3 Yr. CAGR %	60.62	20.41	15.49	-9.65	6.71
Net Income, 3 Yr. CAGR %	60.62	20.41	15.49	-9.65	6.71
Normalized Net Income, 3 Yr. CAGR %	53.24	20.41	14.67	-8.19	3.94
Diluted EPS Before Extra, 3 Yr. CAGR %	58.91	21.39	16.89	-8.67	7.6
Accounts Receivable, 3 Yr. CAGR %	6.8	11.15	12.73	8.8	0.62
Inventory, 3 Yr. CAGR %	40.85	36.56	37.89	18.47	11.12
Net Property, Plant and Equip., 3 Yr. CAGR %	8.22	14.21	17.82	18.98	18.49
Total Assets, 3 Yr. CAGR %	11.52	14.8	14.96	14.13	11.48
Tangible Book Value, 3 Yr. CAGR %	22.79	25.34	19.73	16.97	15.31
Common Equity, 3 Yr. CAGR %	18.56	19.14	15.42	14.07	12.83
Cash From Operations, 3 Yr. CAGR %	772.78	8.19	15.76	0.53	37.68
Capital Expenditures, 3 Yr. CAGR %	-15.29	12.49	30.57	11.94	12.86
Levered Free Cash Flow, 3 Yr. CAGR %	-22.85	23.12	41.01	-49.52	-33.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-20.49	29.45	37.14	-58.5	-16.34
Dividend Per Share, 3 Yr. CAGR %	14.47	14.47	14.47	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.99	21.69	21.78	14.61	11.52
Gross Profit, 5 Yr. CAGR %	24.15	21.07	23.22	19.71	16
EBITDA, 5 Yr. CAGR %	25.56	19.23	26.81	17.24	10.93
EBITA, 5 Yr. CAGR %	27.4	20.57	29.74	18.61	10.83
EBIT, 5 Yr. CAGR %	26.79	20.06	29.53	18.54	11.37
Earnings From Cont. Operations, 5 Yr. CAGR %	34.9	20.2	31.26	11.38	8.38
Net Income, 5 Yr. CAGR %	34.9	20.2	31.26	11.38	8.38
Normalized Net Income, 5 Yr. CAGR %	30.79	19.97	28.56	11.02	6.71
Diluted EPS Before Extra, 5 Yr. CAGR %	30.36	17.28	30.87	12.5	9.48
Accounts Receivable, 5 Yr. CAGR %	15.32	17.23	8.59	7.92	7.31
Inventory, 5 Yr. CAGR %	25.25	29.45	32.64	27.62	25.09
Net Property, Plant and Equip., 5 Yr. CAGR %	17.8	17.95	13.42	14.58	18.48
Total Assets, 5 Yr. CAGR %	18.9	19.16	12.87	13.1	14.13
Tangible Book Value, 5 Yr. CAGR %	26.28	27.03	20.44	20.71	18.77
Common Equity, 5 Yr. CAGR %	26.85	23.41	16.8	16.09	15.04
Cash From Operations, 5 Yr. CAGR %	23.35	12.02	308.37	10.88	12.72
Capital Expenditures, 5 Yr. CAGR %	10.84	4.67	-1.66	6.38	25.38
Levered Free Cash Flow, 5 Yr. CAGR %	-4.8	-1.61	-19.51	-18.23	-4.79
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.35	-0.37	-16.81	-23.46	3.2
Dividend Per Share, 5 Yr. CAGR %	18.2	10.76	8.45	8.45	8.45